Intertransverse Process Block for Postoperative Acute Pain After Coronary Bypass Surgery
Launched by MUSTAFA AYDEMIR · Mar 27, 2025
Trial Information
Current as of September 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a method called bilateral intertransverse process block (ITPB) to see if it can help reduce pain after coronary artery bypass grafting (CABG) surgery, which is a common heart surgery. In this trial, patients who are scheduled for this surgery will be randomly chosen to receive either the ITPB treatment or a placebo (a harmless saltwater injection) before their operation. The researchers will then monitor how much pain the patients feel after the surgery, how much pain medicine they need, and how well they recover during the first 24 hours after waking up from anesthesia.
To participate in this study, patients must be at least 18 years old and have planned, non-emergency CABG surgery. They should be able to give their consent and communicate their symptoms clearly to the research team. However, individuals with certain conditions, like those requiring emergency surgery or having infections at the injection site, will not be eligible. If you’re interested in this trial, it’s important to know that it’s not yet recruiting participants, but it aims to help improve pain management for heart surgery patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years
- • Elective coronary artery bypass grafting (CABG) via median sternotomy planned
- • Able to provide written informed consent
- • Able to communicate symptoms reliably with the research team
- Exclusion Criteria:
- • Emergency CABG surgery
- • Infection or open wound at the injection site
- • Coagulopathy
- • Hepatic or renal failure
- • Reoperation cases
- • Incomplete or missing data
About Mustafa Aydemir
Mustafa Aydemir is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and evidence-based practices, he leads initiatives that bridge the gap between scientific discovery and clinical application. Mustafa's extensive experience in trial design, regulatory compliance, and patient engagement ensures that studies are conducted efficiently and ethically. His collaborative approach fosters partnerships with healthcare professionals and research institutions, promoting rigorous investigation and the translation of findings into meaningful healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Konya, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported